Beyond its pro-tumorigenic roles, IL-6 promotes angiogenesis by the VEGF signal pathway, thereby weakening the effectiveness of ICIs in many types of cancers, including gastrointestinal cancers, prostate cancer, oral squamous cell carcinoma, and hepatocellular carcinoma (38–40). Here, IL6 is linked to hepatocellular carcinoma.